Skip to main content
SPRO logo

SPRO · Spero Therapeutics, Inc.

$1.22 +0.06 (+4.74%)
Market Cap
$67.17M
Shares
57.90M

Total shares sold short and not yet covered, reported to FINRA by broker-dealers and published twice a month (bi-monthly). Days to cover divides the short position by average daily volume; a high value (above 5) can signal short-squeeze potential.

Short Squeeze Score
58/100
Short interest 4.9% of shares — P73 Days to cover 1.0 — P31 Price vs VWAP -46.1% — P4 Short-volume trend +12.8% — P87 Short interest change +56.4% — P89 Worst FTD 0.08% of shares — P73

Peer-relative percentile rank across all stocks reporting short interest at the latest settlement date (2026-06-30). Weighted mean of the available factors (short interest 30%, days to cover 20%, price vs VWAP 15%, short-volume trend 15%, short-interest change 10%, fails-to-deliver 10%) plus catalyst boosts (price spike, volume surge, earnings within days), capped at +20 and clamped to 100.

Short Interest History

Settlement Date Current Position Previous Position Change Days to Cover
2026-06-30 2,864,850 1,831,713 +1,033,137 1.04
2026-06-15 1,831,713 1,706,545 +125,168 2.25
2026-05-29 1,706,545 1,647,297 +59,248 1.96
2026-05-15 1,647,297 1,179,702 +467,595 2.61
2026-04-30 1,179,702 737,720 +441,982 3.06
2026-04-15 737,720 605,311 +132,409 1.39
2026-03-31 605,311 537,411 +67,900 1.86
2026-03-13 537,411 574,027 -36,616 1.72
2026-02-27 574,027 715,694 -141,667 2.12
2026-02-13 715,694 941,659 -225,965 1.68
2026-01-30 941,659 1,039,613 -97,954 4.01
2026-01-15 1,039,613 946,767 +92,846 4.43
2025-12-31 946,767 1,056,013 -109,246 3.85
2025-12-15 1,056,013 825,698 +230,315 3.51
2025-11-28 825,698 615,735 +209,963 2.14
2025-11-14 615,735 476,137 +139,598 1.05
2025-10-31 476,137 315,715 +160,422 1.00
2025-10-15 315,715 549,473 -233,758 1.00
2025-09-30 549,473 458,620 +90,853 2.06
2025-09-15 458,620 503,998 -45,378 1.32
2025-08-29 503,998 927,158 -423,160 1.35
2025-08-15 927,158 1,379,953 -452,795 1.00
2025-07-31 1,379,953 1,217,101 +162,852 2.25
Showing 1–23 of 23 settlements
Key facts CIK 1701108 CUSIP 84833T103 13F (30d) 6 filings 6 filers Visit website Investor relations